Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
971,102
-
Shares change
-
-94,937
-
Total reported value, excl. options
-
$7,262,000
-
Value change
-
-$896,616
-
Number of buys
-
7
-
Number of sells
-
-8
-
Price
-
$7.48
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q3 2022
27 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q3 2022.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 971,102 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (202,729 shares), RENAISSANCE TECHNOLOGIES LLC (137,586 shares), Bleichroeder LP (101,594 shares), Cresset Asset Management, LLC (96,426 shares), MORGAN STANLEY (74,074 shares), SHUFRO ROSE & CO LLC (62,408 shares), GEODE CAPITAL MANAGEMENT, LLC (38,135 shares), PERRITT CAPITAL MANAGEMENT INC (36,494 shares), OVERBROOK MANAGEMENT CORP (35,532 shares), and Strategic Financial Services, Inc, (31,000 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.